Get Ready for New Options to Treat Seasonal Allergies

May 2022

You’ll see a plethora of new products and Rx-to-OTC switches for seasonal allergies.

Ryaltris (olopatadine/mometasone) will be a new Rx nasal spray.

Lastacaft (alcaftadine) eye drops have now switched from Rx to OTC. Nasonex (mometasone) nasal spray will switch later this year...so will Astepro 0.15% (azelastine), the first nasal antihistamine to go OTC.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Heart Failure Put New Heart Failure Guidelines in Perspective
Respiratory & Allergy Get Ready for New Options to Treat Seasonal Allergies
Liver Disease Identify Common Culprits of Drug-Induced Liver Injury
Gastroenterology Know When to Hold Antithrombotics Around a Colonoscopy
Insulin Help Patients Avoid Problems With Insulin Pumps
Travel Medicine Share Strategies for Traveling With Meds
Wound Care Aim for Moisture Balance When Managing Pressure Ulcers
Parkinson's Disease Compare First-Line Meds for Parkinson’s
OTC Products Consider Nuances With Condoms
Diabetes Individualize Treatment of Inpatient Hyperglycemia
Psychiatry Weigh Options to Treat SEVERE Acute Agitation

Get Ready for New Options to Treat Seasonal Allergies

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents